A framework for assessing the impact of pharmaceutical reimbursement policies on incentives to innovate
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2015-12-01
|
| Series: | Journal of Pharmaceutical Policy and Practice |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1186/2052-3211-8-S1-P26 |
| _version_ | 1827359364037476352 |
|---|---|
| author | Elizabeth Docteur Joshua Cohen Brian K Bruen Ruth Lopert Avi Dor Chuck Shih |
| author_facet | Elizabeth Docteur Joshua Cohen Brian K Bruen Ruth Lopert Avi Dor Chuck Shih |
| author_sort | Elizabeth Docteur |
| collection | DOAJ |
| first_indexed | 2024-03-08T06:27:54Z |
| format | Article |
| id | doaj.art-ffbf7cc446874c1dba230b3754167c1e |
| institution | Directory Open Access Journal |
| issn | 2052-3211 |
| language | English |
| last_indexed | 2024-03-08T06:27:54Z |
| publishDate | 2015-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Journal of Pharmaceutical Policy and Practice |
| spelling | doaj.art-ffbf7cc446874c1dba230b3754167c1e2024-02-03T13:32:03ZengTaylor & Francis GroupJournal of Pharmaceutical Policy and Practice2052-32112015-12-018sup110.1186/2052-3211-8-S1-P26A framework for assessing the impact of pharmaceutical reimbursement policies on incentives to innovateElizabeth Docteur0Joshua Cohen1Brian K Bruen2Ruth Lopert3Avi Dor4Chuck Shih5Elizabeth Docteur Consulting, Alexandria VA 22314, USA.Tufts University,Tufts Center for the Study of Drug Development, Boston, MA, 02111, USA.George Washington University, Milken Institute of Public Health and Health Services,Department of Health Policy, NW. Washington, DC, 20052, USA.George Washington University, Milken Institute of Public Health and Health Services,Department of Health Policy, NW. Washington, DC, 20052, USA.George Washington University, Milken Institute of Public Health and Health Services,Department of Health Policy, NW. Washington, DC, 20052, USA.The Pew Charitable Trusts, 901 E Street, NW, Washington, DC, 20004-2008, USA.https://www.tandfonline.com/doi/10.1186/2052-3211-8-S1-P26Analytical FrameworkRadical InnovationSales PriceTherapeutic AdvantageReimbursement Policy |
| spellingShingle | Elizabeth Docteur Joshua Cohen Brian K Bruen Ruth Lopert Avi Dor Chuck Shih A framework for assessing the impact of pharmaceutical reimbursement policies on incentives to innovate Journal of Pharmaceutical Policy and Practice Analytical Framework Radical Innovation Sales Price Therapeutic Advantage Reimbursement Policy |
| title | A framework for assessing the impact of pharmaceutical reimbursement policies on incentives to innovate |
| title_full | A framework for assessing the impact of pharmaceutical reimbursement policies on incentives to innovate |
| title_fullStr | A framework for assessing the impact of pharmaceutical reimbursement policies on incentives to innovate |
| title_full_unstemmed | A framework for assessing the impact of pharmaceutical reimbursement policies on incentives to innovate |
| title_short | A framework for assessing the impact of pharmaceutical reimbursement policies on incentives to innovate |
| title_sort | framework for assessing the impact of pharmaceutical reimbursement policies on incentives to innovate |
| topic | Analytical Framework Radical Innovation Sales Price Therapeutic Advantage Reimbursement Policy |
| url | https://www.tandfonline.com/doi/10.1186/2052-3211-8-S1-P26 |
| work_keys_str_mv | AT elizabethdocteur aframeworkforassessingtheimpactofpharmaceuticalreimbursementpoliciesonincentivestoinnovate AT joshuacohen aframeworkforassessingtheimpactofpharmaceuticalreimbursementpoliciesonincentivestoinnovate AT briankbruen aframeworkforassessingtheimpactofpharmaceuticalreimbursementpoliciesonincentivestoinnovate AT ruthlopert aframeworkforassessingtheimpactofpharmaceuticalreimbursementpoliciesonincentivestoinnovate AT avidor aframeworkforassessingtheimpactofpharmaceuticalreimbursementpoliciesonincentivestoinnovate AT chuckshih aframeworkforassessingtheimpactofpharmaceuticalreimbursementpoliciesonincentivestoinnovate AT elizabethdocteur frameworkforassessingtheimpactofpharmaceuticalreimbursementpoliciesonincentivestoinnovate AT joshuacohen frameworkforassessingtheimpactofpharmaceuticalreimbursementpoliciesonincentivestoinnovate AT briankbruen frameworkforassessingtheimpactofpharmaceuticalreimbursementpoliciesonincentivestoinnovate AT ruthlopert frameworkforassessingtheimpactofpharmaceuticalreimbursementpoliciesonincentivestoinnovate AT avidor frameworkforassessingtheimpactofpharmaceuticalreimbursementpoliciesonincentivestoinnovate AT chuckshih frameworkforassessingtheimpactofpharmaceuticalreimbursementpoliciesonincentivestoinnovate |